Biolimus-coated balloon or sirolimus-coated balloon vs paclitaxel-coated balloon for in-stent restenosis: a systematic review and meta-analysis

1 September 2025 (12:15 - 13:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Ms Caterina Lecchi

(Switzerland)

7 More presentations in this session

Presentation thumbnail

Outcomes in functionally guided DCB versus stent PCI: a propensity-matched analysis

Professor A. Leone (Rome, IT)

Abstract Slides Video

Presentation thumbnail

Long-term outcomes of drug coated balloons versus drug eluting stents in patients with small vessel coronary artery disease

Assistant Professor M. Arab (Zagazig, EG)

Abstract Slides Video

Presentation thumbnail

Sex-specific outcomes following percutaneous coronary interventions with drug-coated balloons

Miss L. Stutz (Luzern, CH)

Abstract Slides Video

Presentation thumbnail

Clinical outcomes of stent-less percutaneous coronary intervention with intravascular lithotripsy and drug-coated balloon for severely calcified de novo coronary lesions.

Doctor T. Misawa (Tokyo, JP)

Abstract Slides Video

Presentation thumbnail

Meta-analysis of randomized trials: DEB versus DES in patients with de novo coronary artery disease

Doctor H. Rai (Dublin 7, IE)

Abstract Slides Video

Access the full session

Session thumbnail

Choosing the optimal devices in percutaneous coronary intervention

The Event

Event poster

ESC Congress 2025

1 September 2025 12:15 CET

You may be interested in

Congress Presentation

Treatment of coronary artery disease with sirolimus- versus paclitaxel-coated balloons

Congress Session

Strategies and outcomes in in-stent restenosis

Congress Presentation

Comparative outcomes of drug-coated balloon angioplasty versus second-generation drug-eluting stent for in-stent restenosis: a real-world data analysis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources